Heather Bresch

Biography

Heather Bresch is currently CEO of Mylan, Inc., a leading global pharmaceutical company, and has served the company for 25 years. Bresch started with Mylan as a data-entry clerk and subsequently held roles of increasing responsibility in more than 15 functional areas. She also is a member of the company’s board of directors. Prior to becoming CEO, Bresch served as Mylan’s president, where she was responsible for the day-to-day operations of the company. Before that, she served as Mylan’s chief operating officer and chief integration officer, leading the successful integration of two international acquisitions – Matrix Laboratories and Merck KGaA’s generics business – which more than doubled the size of the company and transformed Mylan from a purely U.S. company to a global one. As CEO, Bresch is leading the next chapter of Mylan’s growth and performance, and further differentiating the company from its competitors by transforming it from a pharmaceutical company into a health care company. This strategy includes plans to double the size of Mylan’s product portfolio and manufacturing capacity between 2012 and 2018, enhance its technologies and capabilities, and develop new services that further enhance Mylan’s relationship with customers and patients. To achieve Mylan’s goals, Bresch emphasizes a collaborative company culture focused on leading, learning, teaching and performing to inspire innovation and help set new standards in health care. 

Research Interest

Political science